Hypnotherapy for treatment of overactive bladder: A randomized controlled trial pilot study

Female Pelvic Medicine and Reconstructive Surgery

Volumn 17, Issue 6, 2011, Pages 308-313

  Komesu, Yuko M ^a   Sapien, Robert E ^a   Rogers, Rebecca G ^a   Ketai, Loren H ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Complementary alternative medicine; Hypnotherapy; Overactive bladder

Indexed keywords

ALTERNATIVE MEDICINE; HYPNOTHERAPY; OVERACTIVE BLADDER; PILOT STUDIES; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL DIFFERENCES; STATISTICAL SIGNIFICANCE; THERAPY TREATMENT;

MEDICINE;

EID: 84856484075     PISSN: 21518378     EISSN: None     Source Type: Journal    
DOI: 10.1097/SPV.0b013e31823a08d9     Document Type: Article

References (18)

1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29(1):4-20.
2. Miller J, Hoffman E. The causes and consequences of overactive bladder. J Womens Health 2006;15:251-260. (Pubitemid 43891178)
3. Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology 2010;75(3): 526-532.e1-e18.
4. Coyne KS, Matza LS, Brewster-Jordan J. "We have to stop again?!": The impact of overactive bladder on family members. Neurourol Urodyn 2009;28(8):969-975.
5. D'Souza AO, Smith MJ, Miller LA, et al. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in regional managed care plan. J Manag Care Pharm 2008;14(3):291-301. (Pubitemid 351711980)
6. Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998;280(23):1995-2000.
7. Kleeman S, Karram MM. Overactive bladder syndrome and nocturia. In: Walters MD, Karram MM, eds. Urogynecology and Reconstructive Pelvic Surgery. Philadelphia, PA: Mosby Elsevier; 2007:353-376.
8. Green JP, Barabasz AF, Barrett D, et al. Forging ahead: the 2003 APA Division 30 definition of hypnosis. Int J Clin Exp Hypn 2005;53(3):259-264. (Pubitemid 40967275)
9. Freeman RM, Baxby K. Hypnotherapy for incontinence caused by the unstable detrusor. Br Med J (Clin Res Ed) 1982;284(6332): 1831-1834. (Pubitemid 12123660)
10. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003;289:98-101. (Pubitemid 36886531)
11. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002;11(6):563-574. (Pubitemid 34876130)
12. Coyne KS, Zyczynski T, Margolis MK, et al. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther 2005;22(4):381-394. (Pubitemid 43003328)
13. Srikirishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J 2010;21:523-528.
14. Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of Overactive Bladder in Women. Evidence Report/Technology Assessment No. 187. Prepared by the Vanderbilt Evidence-Based Practice Center under contract no. 290-2007-10065-I. AHRQ Publication 2009; 09-#017. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
15. Glazener CM, Evans JH, Cheuk DK. Complementary and miscellaneous interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2005;2:CD005230.
16. Crosby RD, Kolotkin RL, Rhys Williams G. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395.
17. Fowler CJ, Griffiths D. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn 2010;29:49-55.
18. Blok BFM, Groen J, Ruud Bosch FLH, et al. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int 2006;98(6): 1238-1243. (Pubitemid 44721234)